RESUMEN
The bone marrow is the largest reserve of stem cells into the body, consisting of stromal cells/mesenchymal niches and hematopoietic system. These cells can differentiate as different lineages as osteogenic, chondrogenic and adipogenic. The bone marrow stem cells population has widely used and an attractive target for potential therapeutic treatment for ple-clinical trials, due its high plasticity of differentiation. Thus, with this review we aimed to show an overview of stem cells and mainly bone marrow cells with basic concepts, as well as their potential new venues for treatment in regenerative veterinary medicine.(AU)
A medula óssea é a maior reserva de células-tronco do corpo, cujo consistem em células mesenquimais e hematopoiéticas. Estascélulas têm a capacidade de diferenciar-se em varias linhagens, como osteogênicas, condrogênicas e adipogênicas. A populaçãode células-tronco derivadas da medula óssea tem sido um alvo atraente para tratamentos terapêuticos e ensaios pré-clínicos,devido sua elevada plasticidade e capacidade de diferenciação. Assim, esta revisão objetiva mostrar uma visão geral das célulastroncoe principalmente conceitos básicos sobre as células da medula óssea, bem como os seus potenciais e novos espaços parao tratamento regenerativo na medicina veterinária.(AU)
Asunto(s)
Animales , Células Madre Mesenquimatosas , Medicina Veterinaria/tendencias , Plasticidad de la Célula , Médula ÓseaRESUMEN
The bone marrow is the largest reserve of stem cells into the body, consisting of stromal cells/mesenchymal niches and hematopoietic system. These cells can differentiate as different lineages as osteogenic, chondrogenic and adipogenic. The bone marrow stem cells population has widely used and an attractive target for potential therapeutic treatment for ple-clinical trials, due its high plasticity of differentiation. Thus, with this review we aimed to show an overview of stem cells and mainly bone marrow cells with basic concepts, as well as their potential new venues for treatment in regenerative veterinary medicine.
A medula óssea é a maior reserva de células-tronco do corpo, cujo consistem em células mesenquimais e hematopoiéticas. Estascélulas têm a capacidade de diferenciar-se em varias linhagens, como osteogênicas, condrogênicas e adipogênicas. A populaçãode células-tronco derivadas da medula óssea tem sido um alvo atraente para tratamentos terapêuticos e ensaios pré-clínicos,devido sua elevada plasticidade e capacidade de diferenciação. Assim, esta revisão objetiva mostrar uma visão geral das célulastroncoe principalmente conceitos básicos sobre as células da medula óssea, bem como os seus potenciais e novos espaços parao tratamento regenerativo na medicina veterinária.
Asunto(s)
Animales , Células Madre Mesenquimatosas , Medicina Veterinaria/tendencias , Médula Ósea , Plasticidad de la CélulaRESUMEN
During fetal development, mesenchymal progenitor (MP) cells are co-localized in major hematopoietic territories, such as yolk sac (YS), bone marrow (BM), liver (LV), and others. Studies using mouse and human MP cells isolated from fetus have shown that these cells are very similar but not identical to adult mesenchymal stem cells (MSC). Their differentiation potential is usually restricted to production of highly committed osteogenic and chondrogenic precursors. Such properties of fetal MP cells can be very useful for tissue regeneration, when a great number of committed precursors are required. The objectives of this study were to isolate and characterize MP cells from canine YS, BM, and LV in early and late stages of fetal development. Gestational stage was identified, and cell culture conditions were evaluated for efficient isolation of canine MP cells. All canine fetal MP cells expressed vimentin, nestin, and CD44 proteins. Cytokeratin 18 expression was observed in BM- and LV-MP cells, and vascular endothelial (VE)-cadherin expression was observed only in YS-MP cells. A small number of MP cells (5%) from LV and YS expressed Oct3/4 protein. The differentiation potential of canine fetal MP cells varied significantly: YS- and BM-MP cells differentiated into bone and cartilage, whereas LV-MP cells differentiation was limited to osteogenic fate. None of the canine fetal MP cells were able to differentiate into adipose cells. Our data suggest that canine fetal MP cells are an appropriate in vitro model to study MP biology from hematopoietic territories and they are a source of committed osteogenic and chondrogenic precursors for regenerative medicine.